Skip to main content
Clinical Trials/CTRI/2014/11/005182
CTRI/2014/11/005182CompletedPhase 4

Title-â??The Effect of Epidural dexmedetomidine on oxygenation and shunt fraction in patients undergoing thoracotomy and one lung ventilationâ??

izams institute of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 18-60 yrs, ASA I-II patients undergoing Thoracotomy and one lung ventilation for lung surgery.

Exclusion Criteria

  • Contraindication to Epidural anaesthesia, Known allergy to study drugs, Documented severe cardiovascular disease, H/o Myocardial infarction, arrhythmias, Hypertensives on treatment with alpha2 agonists, Severe neuropsychiatric disease, renal dysfunction(S.cr >1.5gm/dl), Hepatic dysfunction, Long term alcohol or other drug addiction.
  • Intraoperative exclusion criteria- If Spo2 decreased to < 92% at any point of time, Requirement of PEEP for maintaining oxygenation, Improper lung isolation, Significant bleed ( Hb < 8 despite transfusion), Failed Epidural, Haemodynamic fluctuations requiring use of Vasoactive drug.

Investigators

Sponsor
izams institute of Medical Sciences

Similar Trials

Efficacy of Dexmedetomidine given through... | Clinical Trial